Biology Reference
In-Depth Information
Nakata M, Smyth MJ, Norihisa Y, Kawasaki A, Shinkai Y, Okumura K, Yagita H. 1990. Con-
stitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implica-
tion for their cytotoxic role in vivo. J Exp Med 172: 1877±1880.
Nilssen DE, Muller F, Oktedalen O, Froland SS, Fausa O, Halstensen TS, Brandtzaeg P. 1996.
Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and
survival time in AIDS. J Virol 70: 3545±3550.
Pardoll DM, Fowlkes BJ, Bluestone JA, Kruisbeek A, Maloy WL, Coligan JE, Schwartz RH. 1987.
Di¨erential expression of two distinct T-cell receptors during thymocyte development. Nature
326: 79±81.
Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner
MB. 1990. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J
Exp Med 171: 1597±1612.
Pechhold K, Wesch D, Schondelmaier S, Kabelitz D. 1994. Primary activation of V gamma 9-
expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4
T cell help and inhibition by IL-10. J Immunol 152: 4984±4992.
Peyrat MA, Davodeau F, Houde I, Romagne F, Necker A, Leget C, Cervoni JP, Cerf-Bensussan
N, Vie H, Bonneville M, et al. 1995. Repertoire analysis of human peripheral blood lymphocytes
using a human V delta 3 region-speci®c monoclonal antibody. Characterization of dual T cell
receptor (TCR) delta-chain expressors and alpha beta T cells expressing V delta 3J alpha C
alpha-encoded TCR chains. J Immunol 155: 3060±3067.
Pfe¨er K, Schoel B, Gulle H, Kaufmann SH, Wagner H. 1990. Primary responses of human T cells
to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant
ligands. Eur J Immunol 20: 1175±1179.
Pfe¨er K, Schoel B, Plesnila N, Lipford GB, Kromer S, Deusch K, Wagner H. 1992. A lectin-
binding, protease-resistant mycobacterial ligand speci®cally activates V gamma 9 human
gamma delta T cells. J Immunol 148: 575±583.
Poccia F, Boullier S, Lecoeur H, Cochet M, Poquet Y, Colizzi V, Fournie JJ, Gougeon ML. 1996.
Peripheral V gamma9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial anti-
gens in asymptomatic HIV-1-infected persons. J Immunol 157: 449±461.
Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, Lopez-Botet M, Fournie JJ,
Gougeon ML. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and
anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lympho-
cytes. J Immunol 159: 6009±6017.
Poccia F, Battistini L, Cipriani B, Mancino G, Martini F, Gougeon ML, Colizzi V. 1999.
Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immuno-
de®ciency virus type 1 replication by cell-released antiviral factors including CC chemokines. J
Infect Dis 180: 858±861.
Poggi A, Bottino C, Zocchi MR, Pantaleo G, Ciccone E, Mingari C, Moretta L, Moretta A. 1987.
CD3
WT31
ÿ
peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in acti-
vation of T cells bearing the alpha/beta heterodimer. Eur J Immunol 17: 1065±1068.
Poquet Y, Constant P, Halary F, Peyrat MA, Gilleron M, Davodeau F, Bonneville M, Fournie JJ.
1996a. A novel nucleotide-containing antigen for human blood gamma delta T lymphocytes.
Eur J Immunol 26: 2344±2349.
Poquet Y, Halary F, Champagne E, Davodeau F, Gougeon ML, Bonneville M, Fournie JJ. 1996b.
Human gamma delta T cells in tuberculosis. Res Immunol 147: 542±549.
Porcelli S, Brenner MB, Band H. 1991. Biology of the human gamma delta T-cell receptor. Im-
munol Rev 120: 137±183.
Quertermous T, Murre C, Dialynas D, Duby AD, Strominger JL, Waldman TA, Seidman JG.
1986a. Human T-cell gamma chain genes: organization, diversity, and rearrangement. Science
231: 252±255.
